GCM
Graham Capital Management Portfolio holdings
AUM
$3.28B
1-Year Return
7.17%
This Quarter Return
+2.52%
1 Year Return
+7.17%
3 Year Return
+21.95%
5 Year Return
+42.01%
10 Year Return
+61.8%
AUM
$3.03B
AUM Growth
+$132M
(+4.6%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-37.11%
Top 10 Holdings %
Top 10 Hldgs %
32.06%
Holding
1,382
New
385
Increased
286
Reduced
334
Closed
329
Top Buys
| 1 |
iShares Bitcoin Trust
IBIT
|
+$38.6M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$22.1M |
| 3 |
NVIDIA
NVDA
|
+$20.6M |
| 4 |
Netflix
NFLX
|
+$18M |
| 5 |
Bank of America
BAC
|
+$17.5M |
Top Sells
| 1 |
Strategy Inc Common Stock Class A
MSTR
|
+$57.6M |
| 2 |
Coca-Cola
KO
|
+$16M |
| 3 |
State Street
STT
|
+$15M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$13.8M |
| 5 |
CMS Energy
CMS
|
+$12.3M |
Sector Composition
| 1 | Technology | 11.03% |
| 2 | Industrials | 8.28% |
| 3 | Financials | 7.02% |
| 4 | Consumer Discretionary | 5.42% |
| 5 | Healthcare | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Under Armour
UAA
$2.14B
| $228K | ﹤0.01% |
25,584
-45,862
| -64% | -$409K |
|
|
AHH
827
Armada Hoffler Properties
AHH
$576M
| $227K | ﹤0.01% |
+20,983
| New | +$227K |
|
|
DNMR
828
DELISTED
Danimer Scientific, Inc.
DNMR
| $227K | ﹤0.01% |
12,500
| – | – |
|
|
OPI
829
Office Properties Income Trust
OPI
$18.7M
| $223K | ﹤0.01% |
102,186
-23,807
| -19% | -$51.9K |
|
830
Marten Transport
MRTN
$949M
| $221K | ﹤0.01% |
+12,462
| New | +$221K |
|
831
Amylyx Pharmaceuticals
AMLX
$1.05B
| $220K | ﹤0.01% |
67,956
-253,911
| -79% | -$823K |
|
832
Ardmore Shipping
ASC
$502M
| $218K | ﹤0.01% |
+12,018
| New | +$218K |
|
833
First Foundation Inc
FFWM
$487M
| $217K | ﹤0.01% |
34,777
+17,063
| +96% | +$106K |
|
834
Independent Bank
INDB
$3.46B
| $215K | ﹤0.01% |
3,642
-7,835
| -68% | -$463K |
|
835
4D Molecular Therapeutics
FDMT
$324M
| $214K | ﹤0.01% |
19,773
+5,124
| +35% | +$55.4K |
|
836
Bausch Health
BHC
$2.64B
| $213K | ﹤0.01% |
+26,065
| New | +$213K |
|
837
Axos Financial
AX
$5.19B
| $212K | ﹤0.01% |
3,379
-19,466
| -85% | -$1.22M |
|
838
Workiva
WK
$4.24B
| $212K | ﹤0.01% |
+2,678
| New | +$212K |
|
839
Stoke Therapeutics
STOK
$1.24B
| $211K | ﹤0.01% |
+17,181
| New | +$211K |
|
840
Lear
LEA
$5.76B
| $210K | ﹤0.01% |
1,926
-7,881
| -80% | -$860K |
|
841
Huntington Bancshares
HBAN
$25.8B
| $209K | ﹤0.01% |
+14,230
| New | +$209K |
|
842
ODP
ODP
$611M
| $209K | ﹤0.01% |
+7,013
| New | +$209K |
|
843
Arcosa
ACA
$4.72B
| $208K | ﹤0.01% |
2,200
-472
| -18% | -$44.7K |
|
844
Ardelyx
ARDX
$1.6B
| $208K | ﹤0.01% |
30,139
-12,392
| -29% | -$85.4K |
|
845
Stitch Fix
SFIX
$745M
| $208K | ﹤0.01% |
+73,593
| New | +$208K |
|
846
Arcutis Biotherapeutics
ARQT
$2.11B
| $207K | ﹤0.01% |
22,286
-43,879
| -66% | -$408K |
|
|
GTY
847
Getty Realty Corp
GTY
$1.6B
| $207K | ﹤0.01% |
+6,511
| New | +$207K |
|
848
Fidelis Insurance
FIHL
$1.79B
| $207K | ﹤0.01% |
+11,457
| New | +$207K |
|
849
DocGo
DCGO
$148M
| $205K | ﹤0.01% |
61,783
-20,218
| -25% | -$67.1K |
|
850
CRISPR Therapeutics
CRSP
$4.71B
| $205K | ﹤0.01% |
4,358
-951
| -18% | -$44.7K |
|